In millions, except per share items | Sep-30-22 | Sep-30-21 | Sep-30-20 | Sep-30-19 | Sep-30-18 | Sep-30-17 | Sep-30-16 | Sep-30-15 |
| 10-K | 10-K | 10-K | 10-K/A | 10-K | 10-K | 10-K | 10-K |
Interest income: |
Interest income on loans | 31.8 | 36.4 | 41.4 | 43.8 | 36.9 | 30.8 | 21.2 | 16.5 |
Interest income on investments | 2.6 | 1.6 | 1.2 | 1.2 | 1.3 | 2.1 | 3.6 | 3.6 |
| 35.0 | 38.4 | 44.3 | 47.8 | 40.0 | 33.8 | 25.2 | 20.5 |
Interest expense: |
Interest on deposits | 3.5 | 6.7 | 12.8 | 14.3 | 9.2 | 6.2 | 4.5 | 3.4 |
| 13.5 | 25.9 | 45.9 | 50.3 | 13.0 | 9.4 | 6.7 | 5.2 |
Net interest income | 29.3 | 28.1 | 27.0 | 29.1 | 27.0 | 24.3 | 18.5 | 15.2 |
Provision for loan losses | | 11.2 | 10.6 | 2.4 | 1.0 | 2.8 | 0.9 | 0.1 |
Net interest income after provision for loan losses | 29.3 | 16.9 | 16.4 | 26.7 | 26.1 | 21.5 | 17.6 | 15.1 |
Deposit and loan fees | | | | | | | | 1.0 |
Gain on sale of investments, net | | | | | | -0.5 | -0.6 | |
Other non-interest income | 2.3 | 3.8 | 2.5 | 2.6 | 3.3 | 2.8 | 2.9 | 1.5 |
Total non-interest income | 2.3 | 3.8 | 2.5 | 2.6 | 3.3 | 2.3 | 2.3 | 2.5 |
Non-interest expenses | 22.8 | 21.0 | 18.3 | 17.5 | 17.8 | 15.1 | 13.9 | 14.0 |
Pre-tax income before non-recurring items | 8.9 | -0.3 | 0.6 | 11.8 | 11.6 | 8.7 | 6.0 | 2.7 |
Non-recurring items | | | | | | | 0.0 | |
Pre-tax income | 8.9 | -0.3 | 0.6 | 11.8 | 11.6 | 8.7 | 6.0 | 2.7 |
Income taxes | 1.9 | -0.2 | 0.0 | 2.5 | 4.3 | 2.9 | -6.2 | -1.0 |
Tax rate | 21.7% | 69.7% | | 20.9% | 36.9% | 33.4% | | |
Net income | 7.0 | -0.1 | 0.6 | 9.3 | 7.3 | 5.8 | 12.2 | 3.7 |
Net margin | 22.0% | -0.4% | 3.4% | 31.9% | 24.9% | 24.4% | 61.1% | 20.9% |
|
Basic EPS | $0.92 | ($0.01) | $0.08 | $1.22 | $1.13 | $0.90 | $1.90 | $0.58 |
Diluted EPS | $0.92 | ($0.01) | $0.08 | $1.22 | $1.13 | $0.90 | $1.90 | $0.58 |
|
Shares outstanding (basic) | 7.6 | 7.5 | 7.6 | 7.6 | 6.5 | 6.4 | 6.4 | 6.4 |
Shares outstanding (diluted) | 7.6 | 7.5 | 7.6 | 7.6 | 6.5 | 6.4 | 6.4 | 6.4 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |